Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial

dc.contributor.authorDancey, G.
dc.date.accessioned2023-06-07T14:09:07Z
dc.date.available2023-06-07T14:09:07Z
dc.date.issued2017
dc.identifier.citationSzlosarek, P. W., Steele, J. P., Nolan, L., Gilligan, D., Taylor, P., Spicer, J., Lind, M., Mitra, S., Shamash, J., Phillips, M. M., Luong, P., Payne, S., Hillman, P., Ellis, S., Szyszko, T., Dancey, G., Butcher, L., Beck, S., Avril, N. E., Thomson, J., Johnston, A., Tomsa, M., Lawrence, C., Schmid, P., Crook, T., Wu, B. W., Bomalaski, J. S., Lemoine, N., Sheaff, M. T., Rudd, R. M., Fennell, D. & Hackshaw, A. 2017. Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial. JAMA oncology, 3, (1) 58-66.
dc.identifier.doihttps://dx.doi.org/10.1001/jamaoncol.2016.3049
dc.identifier.issn2374-2445
dc.identifier.journalJAMA oncology
dc.identifier.urihttps://hdl.handle.net/20.500.14265/1968
dc.language.isoEnglish
dc.publisherAmerican Medical Association
dc.source.issue1
dc.source.pages58-66
dc.source.volume3
dc.titleArginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial
dc.typeArticle
Files